SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?


To: Vector1 who wrote (6912)7/22/1999 12:22:00 AM
From: Vector1  Read Replies (1) | Respond to of 9719
 
Just read an Deuche AB report that CLTR's BLA for Bexxar was granted priority 6 month review status today by the FDA. I can't find this on any of the news services. It could, however, explain the strong performance today. This is excellent news. The FDA had 45 days from June 30 to make this decision. Tang has maintained his 47 per share price target. The guy has balls.

V1